The risk — for companies and for investors — is that there is no track record for such facilities, no history of using 100,000-liter bioreactors, which could be hard to keep clean and even harder to grow cells in. “You can break ground on a lot of facilities before you prove anything, which means that a lot of money can be wasted,” said Ben Wurgaft, a writer and historian who has followed the cultivated meat industry for a decade. “These are substantial gambles.”
Source: Lab to table: The promise and the perils of cell-cultured chicken